Virax Biolabs【VRAX】株式ニュース

名称	銘柄コード	市場	種別
Virax Biolabs Group Ltd	VRAX	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.001	0.06%	1.721	13:00:08

始値	安値	高値	終値	前日終値
1.71	1.65	1.77	1.72	1.72

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/12	05:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/4/25	21:00	PRNUS	Virax Biolabs Launches Portfolio of Immune Profiling..
2024/4/16	20:30	PRNUS	Virax Biolabs to Participate at ESCMID Global 2024
2024/3/16	05:30	PRNUS	Virax Biolabs Announces Receipt of NASDAQ Notification..
2024/1/23	07:28	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/23	07:27	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/12	21:43	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/21	21:34	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/21	21:30	PRNUS	Virax Biolabs Forges Strategic Research Collaboration with..
2023/12/21	06:12	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/12/21	06:06	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/21	06:03	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/12/18	21:37	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/18	21:30	PRNUS	Virax Biolabs' CEO James Foster Issues Letter to..
2023/12/18	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2023/12/14	21:43	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/14	21:30	PRNUS	Virax Biolabs Group Limited Announces 1-for-10 Share..
2023/12/08	20:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/06	06:06	EDGAR2	Form F-3 - Registration statement by foreign private issuers
2023/11/09	06:11	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/01	05:38	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/12	21:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/04	20:24	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/12	20:49	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/12	20:30	PRNUS	Virax Biolabs Group Announces Early-Access Program Launch of..
2023/9/01	20:37	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/01	20:30	PRNUS	Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief..
2023/8/03	21:39	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/03	20:30	PRNUS	Nasdaq Approves 180-Day Extension for Virax Biolabs Group to..
2023/7/18	20:58	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/18	20:30	PRNUS	Virax Biolabs Group Continues Growth and Expansion with the..